References
- Borowitz M J, Hunger S P, Carroll A J, Shuster J J, Pullen D J, Steuber C P, et al. Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis: a Pediatric Oncology Group study. Blood 1993; 82(4)1086–1091
- Hunger S P. Chromosomal translocation involving the E2A gene in acute lymphoblastic leukemia: clinical features and molecular pathogenesis. Blood 1996; 87: 1211–1224
- Kamps M P, Look A T, Baltimore D. The human t(1;19) translocation in pre-B ALL produces multiple nuclear E2A-Pbx1 fusion proteins with differing transforming potentials. Genes Dev 1991; 5(3)358–368
- Uckun F M, Sensel M G, Sather H N, Gaynon P S, Arthur D C, Lange B J, et al. Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the contest of contemporary therapies: a report from the Children's Cancer Group. J Clin Oncol 1998; 16: 527–535
- Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings outcome. A Collaborative Study of the Group Francais de Cytogenetique Hematologique. Blood 1996; 87(8)3135–3142
- Secker-Walker L M, Berger R, Fenaux P, Lai J L, Nelken B, Garson M, et al. Prognostic significance of the balanced t(1;19) and unbalanced der (19)t(1;19) translocations in acute lymphoblastic leukemia. Leukemia 1992; 6(5)363–369
- Gabert J, Vey N, Nabera C B, Hayette S, Macintyre E, Bastard C, et al. Improved outcome of Adult patients with E2A PBX1/t(1;19) positive ALL after intensive therapy: results of the LAL-94 multicentric protocol. Blood 2001; 98: 840a
- Foa R, Vitale A, Mancini M, Cuneo A, Mecucci C, Elia L, et al. E2A-PBX1 fusion in adult acute lymphoblastic leukaemia: biological and clinical features. Br J Haematol 2003; 120(3)484–487
- Zinzani P L, Bendandi M, Visani G, Gherlinzoni F, Frezza G, Merla E, et al. Adult lymphoblastic lymphoma: clinical features and prognostic factors in 53 patients. Leuk Lymphoma 1996; 23: 577–582
- Clarckson B, Gaynor J, Little C, Barman E, Kampin S, Andreeff M, et al. Importance of long term follow up in evaluating treatment regimens for adults with acute lymphoblastic leukemia. Hematol Blood Transfus 1990; 33: 397–408
- Larson R A, Dodge R K, Burns C P, Lee E J, Stone R M, Schulman P, et al. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811. Blood 1995; 85(8)2025–2020
- Hoelzer D, Gokbuget N, Ottmann O, Pui C H, Relling M V, Appelbaum F R, et al. Acute lymphoblastic leukemia. Hematology (Am Soc Hematol Educ Program) 2002; 162–192
- Ross M E, Zhou X, Song G, Shurtleff S A, Girtman K, Williams W K, et al. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood 2003; 102(8)2951–2299
- Yeoh E J, Ross M E, Shurtleff S A, Williams W K, Patel D, Mahfouz R, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002; 1(2)133–143
- Perez-Atayde A R, Sallan S E, Tedrow U, Connors S, Allred E, Folkman J. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 1997; 150(3)815–821
- Fu X, Roberts W G, Nobile V, Shapiro R, Kamps M P. mAngiogenin-3, a target gene of oncoprotein E2a-Pbx1, encodes a new angiogenic member of the angiogenin family. Growth Factors 1999; 17(2)125–137
- Ek S, Hogerkorp C M, Dictor M, Ehinger M, Borrebaeck C A. Mantle cell lymphomas express a distinct genetic signature affecting lymphocyte trafficking and growth regulation as compared with subpopulations of normal human B cells. Cancer Res 2002; 62(15)4398–4405
- Baluk P, Morikawa S, Haskell A, Mancuso M, McDonald D M. Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. Am J Pathol 2003; 163(5)1801–1815
- De Luca A, De Falco M, Severino A, Campioni M, Santini D, Baldi F, et al. Distribution of the serine protease HtrA1 in normal human tissues. J Histochem Cytochem 2003; 51(10)1279–1284
- Van De Geijn G J, Gits J, Touw I P. Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling. J Leukoc Biol 2004; 76: 237–244
- Kobayashi H, Sagara J, Kurita H, Morifuji M, Ohishi M, Kurashina K, et al. Clinical significance of cellular distribution of moesin in patients with oral squamous cell carcinoma. Clin Cancer Res 2004; 10(2)572–580